1 |
Unal E, Idilman IS, Karaosmanoglu AD, Ozmen MN, Akata D, Karcaaltincaba M. Hyperintensity at fat spared area in steatotic liver on the hepatobiliary phase MRI. Diagn Interv Radiol 2019;25:416-420
DOI
|
2 |
Joo I, Lee JM. Recent advances in the imaging diagnosis of hepatocellular carcinoma: value of gadoxetic acid-enhanced MRI. Liver Cancer 2016;5:67-87
DOI
|
3 |
Hui CL, Mautone M. Patterns of enhancement in the hepatobiliary phase of gadoxetic acid-enhanced MRI. Br J Radiol 2020;93:20190989
DOI
|
4 |
World Health Organization Classification of Tumours Editorial Board. Digestive system tumours. 5th ed. World Health Organization: International Agency for Research on Cancer Publications, 2019:485-487
|
5 |
Kim R, Lee JM, Joo I, et al. Differentiation of lipid poor angiomyolipoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging. Abdom Imaging 2015;40:531-541
DOI
|
6 |
Nonomura A, Enomoto Y, Takeda M, et al. Invasive growth of hepatic angiomyolipoma; a hitherto unreported ominous histological feature. Histopathology 2006;48:831-835
DOI
|
7 |
Yoon JH, Lee JM, Kang HJ, et al. Quantitative assessment of liver function by using gadoxetic acid-enhanced MRI: hepatocyte uptake ratio. Radiology 2019;290:125-133
DOI
|
8 |
Zhao C, Li X-y, Pan Y-h, Xie S-d, Zhou J, Chen J-n. Hepatic epithelioid angiomyolipoma with prominent invasive growth pattern: a hitherto unreported histopathologic eature which might promote misdiagnosis. Clin Diagn Pathol 2018;2:1-4
|
9 |
Fujita N, Nishie A, Asayama Y, et al. Hyperintense liver masses at hepatobiliary phase gadoxetic acid-enhanced MRI: imaging appearances and clinical importance. Radiographics 2020;40:72-94
DOI
|
10 |
Lee SJ, Kim SY, Kim KW, et al. Hepatic angiomyolipoma versus hepatocellular carcinoma in the noncirrhotic liver on gadoxetic acid-enhanced MRI: a diagnostic challenge. AJR Am J Roentgenol 2016;207:562-570
DOI
|